Datavant · 2 days ago
Senior Manager, Identity & Access Management
Maximize your interview chances
BiopharmaClinical Trials
No H1B
Insider Connection @Datavant
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Manage and execute IAM solution technology implementations that align with company goals, ensuring reliable access control across systems and applications.
Lead a small team of IAM specialists, providing mentorship, guidance, and hands-on support to drive efficient and secure operations.
Implement IAM policies, standards, and procedures to maintain compliance with industry regulations and internal policies.
Collaborate with IT and other departments to integrate IAM requirements seamlessly within business processes.
Oversee the selection, deployment, and management of IAM tools, including IGA, enhancing scalability and operational efficiency.
Regularly assess and improve IAM configurations and workflows to address evolving security needs and industry trends.
Conduct periodic reviews and audits, implementing improvements based on findings to enhance security and compliance.
Provide IAM-related support for IT security measures to safeguard user data, applications, and systems against unauthorized access.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
Proven experience in IAM management, including successful program implementation and execution.
Strong knowledge of IAM processes, technologies, and compliance requirements (e.g., NIST, FedRAMP).
Ability to lead a small, dedicated team, fostering collaboration, accountability, and professional growth.
Excellent organizational and problem-solving skills, with an emphasis on attention to detail and execution.
Preferred
Relevant certifications such as CISSP, CISM, or similar are a plus.
Company
Datavant
Datavant protects, connects, and delivers the world’s health data to power better decisions and advance human health.
Funding
Current Stage
Late StageTotal Funding
$80.5MKey Investors
Transformation Capital
2020-10-08Series B· $40M
2018-04-30Series Unknown· $40.5M
Leadership Team
Recent News
2024-04-15
Business Insider
2024-04-05
Company data provided by crunchbase